Meckler Jeffrey A: insider trades.
Meckler Jeffrey A reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($1.3M), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- Meckler Jeffrey A
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | Director | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-10 | Travere Therapeutics, Inc. | S | 3,100 | $68.09 | 91,500 | Form 4 |
| 2026-09-10 | Travere Therapeutics, Inc. | S | 14,000 | $67.46 | 94,600 | Form 4 |
| 2026-09-10 | Travere Therapeutics, Inc. | S | 1,200 | $66.15 | 108,600 | Form 4 |
| 2026-09-10 | Travere Therapeutics, Inc. | M | 10,000 | $26.52 | 111,500 | Form 4 |
| 2026-09-10 | Travere Therapeutics, Inc. | M | 10,000 | $17.44 | 101,500 | Form 4 |
| 2026-09-10 | Travere Therapeutics, Inc. | S | 1,700 | $65.39 | 109,800 | Form 4 |
Questions
What stock did Meckler Jeffrey A buy or sell?
Meckler Jeffrey A reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($1.3M), across 1 company.
Is Meckler Jeffrey A the same person as other filers with this name?
This page covers SEC CIK 1506916 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/meckler-jeffrey-a-1506916.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.